Regeneron pharmaceuticals, inc. securities fraud class action lawsuit pending: contact levi & korsinsky before march 10, 2025 to discuss your rights – regn

New york, jan. 16, 2025 (globe newswire) -- levi & korsinsky, llp notifies investors in regeneron pharmaceuticals, inc. ("regeneron" or the "company") (nasdaq: regn) of a class action securities lawsuit.

REGN Ratings Summary

REGN Quant Ranking